|
業務類別
|
-- |
|
業務概覽
|
Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the keyrevenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Consun derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others. |
| 公司地址
| 71, Dongpeng Avenue, Eastern section, Guangzhou Economic and Technological Development, Guangzhou, CHN |
| 電話號碼
| +86 2082264529 |
| 傳真號碼
| +86 2082261886 |
| 公司網頁
| https://www.chinaconsun.com |
| 員工數量
| 3115 |
| Mr. Meng An |
Chairman of the Board and Chief Executive Officer |
-- |
28/04/2026 |
| Mr. Yuk Chuen David Young |
Director and Director, Overseas Business |
-- |
28/04/2026 |
|
|
| Professor Quan Zhu |
Director |
28/04/2026 |
| Mr. Zhongshi Feng |
Independent Director |
28/04/2026 |
| Mr. Zhuoguang LI |
Independent Director |
28/04/2026 |
| Ms. Lihua Zhang |
Director |
28/04/2026 |
| Mr. Meng An |
Chairman of the Board and Chief Executive Officer |
28/04/2026 |
| Professor Yikai Li |
Independent Director |
28/04/2026 |
| Mr. Yuk Chuen David Young |
Director and Director, Overseas Business |
28/04/2026 |
| Mr. Weiwu Duan |
Independent Director |
28/04/2026 |
|
|
|
|
